Brief: Revance Reports Fourth Quarter And Full Year 2022 Financial Results, Provides Corporate Update

Revance Therapeutics

28/02/2023 21:53

Feb 28 (Reuters) - Revance Therapeutics Inc  RVNC.O :
    * REVANCE REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS, PROVIDES CORPORATE UPDATE
    * Q4 EARNINGS PER SHARE VIEW $-0.95, REVENUE VIEW $46.5
MILLION --
REFINITIV IBES DATA
    * PDUFA DATE FOR DAXXIFY® FOR TREATMENT OF CERVICAL DYSTONIA
OF
AUGUST 19, 2023

Source text for Eikon:  ID:nBwbdZtfga 
Further company coverage:  RVNC.O 

 ((Reuters.Briefs@thomsonreuters.com;))